In September 2022, I joined the Beijnen group as a PhD student. Here, my project focuses on the stability of anti-cancer monoclonal antibodies.
In September 2022, I joined the Beijnen group as a PhD student. Here, my project focuses on the stability of anti-cancer monoclonal antibodies.